VV-GMCSF-Lact

AXP000111.1 · Oncolytic virus

Platform
vaccinia virus (LIVP, TK- VGF-)
Originator
Institute of Chemical Biology and Fundamental Medicine SB RAS
Sponsor
Institute of Chemical Biology and Fundamental Medicine SB RAS

Names

NameTypeSource
VV-GMCSF-Lactpreferred name, codecurator, ncit
Double Recombinant Vaccinia Virus VV-GMCSF-Lactsynonymncit

Virus

Role
Oncolytic
Family
Poxviridae
Virus
vaccinia virus (NCBI Taxonomy 10245)
Strain
LIVP
Replication
conditionally replicating
Modifications
thymidine kinase gene replaced by the GM-CSF cassette; vaccinia growth factor gene replaced by the lactaptin cassette
Transgenes
CSF2, lactaptin (RL2)
Route
intratumoral
Source
evidence

Cross-references

NCI Thesaurus
C188116

Approvals

No regulatory approval recorded.

Clinical trials (1)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT05376527Open Multi-cohort Study of the First Phase of Safety of a Drug Based on Double Recombinant Vaccinia Virus VV-GMCSF-LactCompletedPhase 12022-05-112025-02-2734Oncolytic Virotherapy

Recent changes

No changes recorded in its trials yet.

Clinical papers

No confirmed clinical papers yet.

Other papers

Preclinical studies, reviews and other papers that name it.

PubMedTitleJournalYearLinked by
PMID 41901280Oncolytic Virus VV-GMCSF-Lact and Human GM-CSF Against GL261 Glioma in Immunocompetent Mice.Pharmaceuticals (Basel, Switzerland)2026name in title: VV-GMCSF-Lact
PMID 42794508Whole-Transcriptome Profiling of Murine GL261 Glioma Reveals Signatures Consistent with Distinct Immune Reprogramming Induced by Oncolytic Virotherapy with VV-GMCSF-Lact and Anti-PD-1 Therapy.International journal of molecular sciences2026name in title: VV-GMCSF-Lact
PMID 40725231Single-Cell Transcriptomic Changes in Patient-Derived Glioma and U87 Glioblastoma Cell Cultures Infected with the Oncolytic Virus VV-GMCSF-Lact.International journal of molecular sciences2025name in title: VV-GMCSF-Lact
PMID 41148834Efficacy of Oncolytic Virus VV-GMCSF-Lact Against Immunocompetent Glioma.Cells2025name in title: VV-GMCSF-Lact
PMID 38398600Characterizing Aptamer Interaction with the Oncolytic Virus VV-GMCSF-Lact.Molecules (Basel, Switzerland)2024name in title: VV-GMCSF-Lact
PMID 38673835The Recombinant Oncolytic Virus VV-GMCSF-Lact and Chemotherapy Drugs against Human Glioma.International journal of molecular sciences2024name in title: VV-GMCSF-Lact
PMID 39598813Using Computer Modeling and Experimental Methods to Screen for Aptamers That Bind to the VV-GMCSF-LACT Virus.Molecules (Basel, Switzerland)2024name in title: VV-GMCSF-Lact
PMID 37998351Transcriptome Changes in Glioma Cells upon Infection with the Oncolytic Virus VV-GMCSF-Lact.Cells2023name in title: VV-GMCSF-Lact
PMID 35923561The Signaling Pathways Controlling the Efficacy of Glioblastoma Therapy.Acta naturae2022name in abstract: VV-GMCSF-Lact
PMID 34685455Double Recombinant Vaccinia Virus: A Candidate Drug against Human Glioblastoma.Life (Basel, Switzerland)2021name in abstract: VV-GMCSF-Lact
PMID 28951871Recombinant Vaccinia Viruses Coding Transgenes of Apoptosis-Inducing Proteins Enhance Apoptosis But Not Immunogenicity of Infected Tumor Cells.BioMed research international2017name in abstract: VV-GMCSF-Lact
PMID 27708236Engineering of double recombinant vaccinia virus with enhanced oncolytic potential for solid tumor virotherapy.Oncotarget2016name in abstract: Double Recombinant Vaccinia Virus VV-GMCSF-Lact

Notes

Russian double-recombinant vaccinia carrying GM-CSF in the thymidine kinase locus and the milk protein fragment lactaptin in the growth-factor locus. Phase 1 (NCT05376527) first stage reported complete in October 2024.

How to cite

VV-GMCSF-Lact (AXP000111.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000111.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.